http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011217487-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8eb2bfe0b1dcb52f23e407fe8ee7890e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01K2217-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01K1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01K13-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01K11-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B41M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B44F1-10
filingDate 2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efca94b7dddff70647efb37db272cd52
publicationDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011217487-A1
titleOfInvention Packaging material for a pharmaceutical product having a coloured element which at a predetermined temperature discolours partially, revealing a marking, and method for producing this material
abstract It is disclosed a packaging material for a pharmaceutical product. The packaging material comprises a coloured element which at about 38° C. discolours partially, revealing a marking. The element is formed by a first portion forming the marking printed with conventional ink, and a second portion printed with thermochromic ink. The thermochromic ink is coloured below about 38° C. and becomes colourless when this temperature is reached or exceeded. The two portions are arranged so that the first portion is invisible below about 38° C., but becomes visible when this temperature is reached or exceeded.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9460948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009057421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021341340-A1
priorityDate 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4385844-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006241355-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007024465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008086103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5997849-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5591255-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007115662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007171506-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128133149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127749755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128348923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308099

Total number of triples: 34.